PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp

Fetiye Kolayli1, Gulcin Gacar, Aynur Karadenizli

  • 1Mikrobiyoloji ve Klinik Mikrobiyoloji AD, Kocaeli Universitesi, Turkey.

Insights

The PER-1 beta-lactamase gene was detected in 31% of ceftazidime-resistant Acinetobacter spp. and 55.4% of Pseudomonas aeruginosa clinical isolates. This highlights the prevalence of this resistance mechanism in intensive care units.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Beta-lactamases are enzymes that confer resistance to beta-lactam antibiotics.
  • PER-1 type beta-lactamases are a significant cause of resistance to third-generation cephalosporins like ceftazidime.
  • Acinetobacter spp. and Pseudomonas aeruginosa are common Gram-negative pathogens often associated with hospital-acquired infections and multidrug resistance.

Purpose of the Study:

  • To screen for the presence of PER-1 type beta-lactamases in clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa.
  • To determine the prevalence of the bla(PER-1) gene in ceftazidime-resistant strains of these bacteria.
  • To assess the potential contribution of PER-1 beta-lactamases to ceftazidime resistance in intensive care unit (ICU) settings.

Main Methods:

  • Collection of 176 non-repetitive clinical isolates (84 Acinetobacter spp., 92 P. aeruginosa) from seven university hospital ICUs over three months.
  • Screening of all isolates for the presence of bla(PER-1) alleles using the polymerase chain reaction (PCR) technique.
  • Phenotypic confirmation of ceftazidime resistance in the selected isolates.

Main Results:

  • The bla(PER-1) gene was detected in 31% of the tested Acinetobacter spp. isolates.
  • A higher prevalence of the bla(PER-1) gene was observed in Pseudomonas aeruginosa, with 55.4% of isolates testing positive.
  • These findings indicate a significant presence of PER-1 beta-lactamase-producing strains among ceftazidime-resistant Acinetobacter and P. aeruginosa in the studied ICUs.

Conclusions:

  • PER-1 type beta-lactamases are prevalent among ceftazidime-resistant Acinetobacter spp. and Pseudomonas aeruginosa in clinical settings.
  • The high prevalence, particularly in P. aeruginosa, suggests a substantial role for PER-1 in mediating resistance to ceftazidime.
  • These results underscore the importance of surveillance for beta-lactamase-producing organisms in ICUs to guide antimicrobial therapy and infection control strategies.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...